| Market Cap | ₹70,271Cr |
| ROE | 9.77% |
| P/E Ratio(TTM) | 20.54 |
| EPS(TTM) | 58.90 |
| P/B Ratio | 2.01 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.18 |
| Book Value | 603.32 |
| Debt to Equity | 0.22 |
| Face Value | 1 |
| Parent Organisation | Aurobindo Pharma Limited |
| Managing Director | K. Nithyananda Reddy |
| Founded | 1986 |
| NSE Symbol | AUROPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.94 | ||
| Cipla | NA (0.00%) | 22.28 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.62 | ||
| Lupin | NA (0.00%) | 22.26 |